| dc.creator | Karachalios T., Paridis D., Tekos F., Skaperda Z., Veskoukis A.S., Kouretas D. | en |
| dc.date.accessioned | 2023-01-31T08:30:33Z | |
| dc.date.available | 2023-01-31T08:30:33Z | |
| dc.date.issued | 2021 | |
| dc.identifier | 10.1155/2021/5542634 | |
| dc.identifier.issn | 19420900 | |
| dc.identifier.uri | http://hdl.handle.net/11615/74326 | |
| dc.description.abstract | Hip fractures are associated with the highest degree of morbidity and mortality of all fractures in elderly patients and pose a major risk for subsequent fractures. Patients with hip fractures also present accelerated bone turnover despite early stable fracture fixation and early mobilization. We aimed to evaluate oxidative stress in two groups of patients (25 patients each, matched for age, side, and BMI) who underwent internal fixation of hip fractures and total hip arthroplasty for hip osteoarthritis. Blood samples were taken from all patients during admission, the day of surgery, the 4th postoperative day, and the 15th postoperative day. Reduced (GSH) and oxidized (GSSG) glutathione, GSH/GSSG, catalase (CAT), thiobarbituric acid reactive substances (TBARS), protein carbonyls (PC), and total antioxidant capacity (TAC) as a widely used battery of redox biomarkers were recorded from blood samples. Patients with hip fractures who undergo fixation surgery, compared to those with hip osteoarthritis, suffer significant oxidative stress with an active but insufficient first line of oxidative defense, an intensive first line reaction, a very active second line of oxidative defense, and a low plasma antioxidant capacity. Surgery worsened already present lipid- and protein-related tissue damage. The severe oxidative stress observed may explain high morbidity and mortality rates and high bone turnover status, as well as the high incidence of refractures. Furthermore, the question of whether antioxidant therapy measures should be introduced in the management of hip fracture patients is raised. © 2021 Theofilos Karachalios et al. | en |
| dc.language.iso | en | en |
| dc.source | Oxidative Medicine and Cellular Longevity | en |
| dc.source.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85108547939&doi=10.1155%2f2021%2f5542634&partnerID=40&md5=a2ab2e4d9cbcf6696e0c1633b931d17a | |
| dc.subject | Antioxidants | en |
| dc.subject | Arthroplasty | en |
| dc.subject | Biomarkers | en |
| dc.subject | Blood | en |
| dc.subject | Diseases | en |
| dc.subject | Fracture fixation | en |
| dc.subject | Network security | en |
| dc.subject | Orthopedics | en |
| dc.subject | Oxidative stress | en |
| dc.subject | Proteins | en |
| dc.subject | Antioxidant capacity | en |
| dc.subject | Antioxidant therapies | en |
| dc.subject | Hip osteoarthritis | en |
| dc.subject | Internal fixation | en |
| dc.subject | Post-operative days | en |
| dc.subject | Thiobarbituric acid reactive substances | en |
| dc.subject | Total antioxidant capacities (TAC) | en |
| dc.subject | Total hip arthroplasty | en |
| dc.subject | Fracture | en |
| dc.subject | carbonyl derivative | en |
| dc.subject | catalase | en |
| dc.subject | glutathione | en |
| dc.subject | glutathione disulfide | en |
| dc.subject | thiobarbituric acid reactive substance | en |
| dc.subject | aged | en |
| dc.subject | antioxidant activity | en |
| dc.subject | Article | en |
| dc.subject | blood sampling | en |
| dc.subject | body mass | en |
| dc.subject | bone turnover | en |
| dc.subject | clinical article | en |
| dc.subject | DPPH radical scavenging assay | en |
| dc.subject | female | en |
| dc.subject | hip fracture | en |
| dc.subject | hip osteoarthritis | en |
| dc.subject | hospital admission | en |
| dc.subject | human | en |
| dc.subject | morbidity | en |
| dc.subject | mortality rate | en |
| dc.subject | osteosynthesis | en |
| dc.subject | oxidative stress | en |
| dc.subject | postoperative period | en |
| dc.subject | total antioxidant capacity | en |
| dc.subject | total hip replacement | en |
| dc.subject | hip fracture | en |
| dc.subject | hip osteoarthritis | en |
| dc.subject | hip replacement | en |
| dc.subject | oxidative stress | en |
| dc.subject | physiology | en |
| dc.subject | procedures | en |
| dc.subject | very elderly | en |
| dc.subject | Antioxidants | en |
| dc.subject | Blood | en |
| dc.subject | Capacity | en |
| dc.subject | Diseases | en |
| dc.subject | Fracture | en |
| dc.subject | Mortality | en |
| dc.subject | Proteins | en |
| dc.subject | Stresses | en |
| dc.subject | Aged | en |
| dc.subject | Aged, 80 and over | en |
| dc.subject | Arthroplasty, Replacement, Hip | en |
| dc.subject | Hip Fractures | en |
| dc.subject | Humans | en |
| dc.subject | Osteoarthritis, Hip | en |
| dc.subject | Oxidative Stress | en |
| dc.subject | Hindawi Limited | en |
| dc.title | Patients Undergoing Surgery for Hip Fractures Suffer from Severe Oxidative Stress as Compared to Patients with Hip Osteoarthritis Undergoing Total Hip Arthroplasty | en |
| dc.type | journalArticle | en |